Literature DB >> 10204205

Intrauterine management of fetal parvovirus B19 infection.

R L Schild1, R Bald, H Plath, A M Eis-Hübinger, G Enders, M Hansmann.   

Abstract

OBJECTIVES: The aim of our study was to determine the outcome of pregnancies after intrauterine management of fetal parvovirus B19 infection.
DESIGN: Retrospective study.
SUBJECTS: A total of 37 cases of maternofetal parvovirus B19 infection, 35 of which were associated with hydrops fetalis, were referred to our tertiary level center between 1989 and 1996. With regard to fetal hydrops, no apparent cause other than parvovirus B19 infection was found in any patient.
METHODS: In all patients, cordocentesis was performed to assess the degree of fetal anemia. When anemia was present, cordocentesis was followed by intrauterine transfusion with packed red cells into the umbilical vein. Further management depended on the degree of fetal anemia and gestational age and included follow-up fetal blood sampling/transfusion as well as ultrasound examinations as deemed appropriate.
RESULTS: Packed red cell transfusion was performed in 30 patients with significant fetal anemia (Z-score 1.6-7.8 below the mean for gestational age). The fetal hemoglobin values ranged from 2.1 to 9.6 g/dl. Serum levels of platelets in the transfusion group were 9-228 x 10(9)/l with Z-scores in the range of < 1 to 3.8 below the mean. During treatment and follow-up, there were five intrauterine deaths (13.5%), one neonatal death (2.7%) and 31 live births (83.8%).
CONCLUSIONS: Fetal parvovirus infection can lead to marked anemia and hydrops formation. Cordocentesis allows precise assessment of fetal anemia which can then be corrected by intravenous transfusion. Under this regimen, the outcome proved favorable in the majority of fetuses, even those that were severely anemic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10204205     DOI: 10.1046/j.1469-0705.1999.13030161.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  6 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Long term follow up of serostatus after maternofetal parvovirus B19 infection.

Authors:  J Dembinski; A M Eis-Hübinger; J Maar; R Schild; P Bartmann
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

3.  Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study.

Authors:  Philipp Kosian; Astrid Hellmund; Annegret Geipel; Rainer Bald; Otilia-Maria Geist; Paul Böckenhoff; Jorge Jimenez-Cruz; Maria Deja; Brigitte Strizek; Christoph Berg; Ulrich Gembruch
Journal:  Arch Gynecol Obstet       Date:  2022-08-02       Impact factor: 2.493

Review 4.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 5.  [Viral infections of the fetus and newborn infant].

Authors:  S Tremolada; S Delbue; P Ferrante
Journal:  Pediatr Med Chir       Date:  2008 Jul-Aug

6.  Preservative Monitoring of a Greek Woman with Hydrops Fetalis due to Parvovirus B19 Infection.

Authors:  Zacharias Fasoulakis; Panagiotis Antsaklis; Emmanuel N Kontomanolis
Journal:  Case Rep Obstet Gynecol       Date:  2017-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.